| | N, patients | 29 | | Age, years, mean ± SD | 68.8 ± 7.24 | | Gender, male, n (%) | 18 (62.1) | | BMI, mean ± SD | 27.8 ± 4.31 | | Coronary risk factors | | | Diabetes, n (%) | 8 (27.6) | | Dyslipidemia, n (%) | 23 (79.3) | | Hypertension, n (%) | 19 (65.5) | | Current smoking, n (%) | 7 (24.1) | | Prior PCI, n (%) | 7 (24.1) |
| | Clinical presentation | | | Stable angina class 1 (%) | 1 (3.45) | | Stable angina class 2 (%) | 5 (17.2) | | Stable angina class 3 (%) | 1 (3.45) | | Stable angina class 4 (%) | 1 (3.45) | | Unstable angina (%) | 1 (3.45) |
| | Silent ischemia | 3 (10.3) | | Angina equivalent (%) | 17 (58.6) | | Creatinine clearance, ml/min, mean ± SD | 0.82 ± 0.13 | | Ejection fraction, %, median (95% CI) | 60.0 (60.0, 60.0) |
| | Medication | | | ACE-I, n (%) | 13 (44.8) | | Beta-blocker, n (%) | 11 (37.9) | | Calcium channel blockers, n (%) | 4 (13.8) | | Statins, n (%) | 19 (65.5) | | Aspirin, n (%) | 16 (55.2) | | P2Y12 inhibitor, n (%) | 2 (6.9) | | Diuretic, n (%) | 6 (20.7) | | Radial access | 27 (93%) | | Femoral access | 2 (7%) |
| | Angiographic characteristics | | | Vessel, n (%) | | | LAD | 16 (55.2) | | LCX | 7 (24.1) | | RCA | 6 (20.7) | | Diameter stenosis, %, median (IQR) | 20.0 (14.0, 32.0) | | Vessel diameter, mm, mean ± SD | 2.60 ± 0.5 |
|
|
BMI, body mass index; PCI, percutaneous coronary intervention; ACE-I, angiotensin-converting enzyme inhibitor; LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; RCA, right coronary artery.
|
